Lumibird's 2025 Revenue Growth: A Closer Look

Lumibird, a European leader in laser technologies, reported a 2025 revenue of €225.6 million, reflecting an increase of 10.2% at constant scope and exchange rates. The Photonics division led this growth with a 15.0% increase, while the Medical division grew by 5.7%. These results indicate strong momentum amid a challenging international setting.

The Photonics division thrived with significant contributions from the Defense/Space and Medtech sectors. Conversely, the ETS segment faced challenges due to a product range renewal, anticipating recovery by 2026. Meanwhile, the Medical division's performance validated its business model despite competitive pressures.

Geographically, strong growth was evident in the Americas for Photonics and steady gains in Europe and Asia-Pacific for Medical. Analysts observe that Lumibird's EBITDA margin is expected to exceed 19%, consistent with its disciplined, profitable growth strategy.